
Photo: STAT
Health
STAT+: Biotech’s rebound isn’t lifting all boats equally
TL;DR
- Biotech is having a good year, though you wouldn't necessarily know it from how investors are treating positive clinical data.
Short summary
Our full write-up is on its way. For the complete story, read the original report:
Nov 16, 2026 · Updated 11/16/2026, 5:05:07 PM · Reported with: STAT
Sources (1)
NRI Bytes writes its own articles from the reporting below.
STAT — STAT+: Biotech’s rebound isn’t lifting all boats equallyUp next · Health
GMA’s Gio Benitez shares ‘silent killer’ coronary artery disease diagnosis
Read next →
More stories

Health
Why frontline experience and operational research need to come together in the health sector
1h ago

Health
Auditor general can’t commit to timeline on Alberta health contract corruption probe
2h ago

Health
STAT+: Updated health data privacy rule sets standards for sharing records with apps
2h ago

Health
Transgender rights, healthcare should not be compromised
2h ago

Health
What the evidence actually says about menopause and mental health
2h ago
